S-3 S-3 EX-FILING FEES 0001401040 DiaMedica Therapeutics Inc. 0001401040 2025-07-31 2025-07-31 0001401040 1 2025-07-31 2025-07-31 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-3

DiaMedica Therapeutics Inc.

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid 1 Equity Common Shares, no par value per share Other 8,606,425 $ 4.55 $ 39,159,233.75 0.0001531 $ 5,995.28
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 39,159,233.75

$ 5,995.28

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 5,995.28

Offering Note

1

(1) Estimated solely for the purpose of calculating the registration fee. The estimate is made pursuant to Rule 457(c) of the Securities Act of 1933 based on $4.55 per share, which represents the average of the high and low sales prices of the registrant's common shares on July 30, 2025 as reported on The Nasdaq Capital Market. (2) The registrant will not receive any proceeds from the sale of its common shares by the selling shareholders.